BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mazzucchelli S, Truffi M, Fiandra L, Sorrentino L, Corsi F. Targeted approaches for HER2 breast cancer therapy: News from nanomedicine? World J Pharmacol 2014; 3(4): 72-85 [DOI: 10.5497/wjp.v3.i4.72]
URL: https://www.wjgnet.com/2220-3192/full/v3/i4/72.htm
Number Citing Articles
1
Kevin L. Williams. Endotoxin Detection and Control in Pharma, Limulus, and Mammalian Systems2019; : 331 doi: 10.1007/978-3-030-17148-3_8
2
Xue-jun Gao, Ai-qin Li, Xin Zhang, Ping Liu, Jue-Ru Wang, Xia Cai. Thyroid-stimulating hormone (TSH)-armed polymer–lipid nanoparticles for the targeted delivery of cisplatin in thyroid cancers: therapeutic efficacy evaluationRSC Advances 2015; 5(129): 106413 doi: 10.1039/C5RA12588J
3
Truffi Marta, Sorrentino Luca, Mazzucchelli Serena, Fiandra Luisa, Corsi Fabio. What Is the Role of Nanotechnology in Diagnosis and Treatment of Metastatic Breast Cancer? Promising Scenarios for the Near FutureJournal of Nanomaterials 2016; 2016: 1 doi: 10.1155/2016/5436458
4
Bijaideep Dutta, K.C. Barick, P.A. Hassan. Recent advances in active targeting of nanomaterials for anticancer drug deliveryAdvances in Colloid and Interface Science 2021; 296: 102509 doi: 10.1016/j.cis.2021.102509
5
Alberto Juan, Francisco J. Cimas, Iván Bravo, Atanasio Pandiella, Alberto Ocaña, Carlos Alonso-Moreno. Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer TreatmentInternational Journal of Molecular Sciences 2020; 21(17): 6018 doi: 10.3390/ijms21176018